Market Currents
Drug developer Synageva BioPharma (GEVA) drops 2.1% AH after announcing a $60M stock offering -...
-
Wednesday, January 4, 2012, 4:33 PM ETDrug developer Synageva BioPharma (GEVA) drops 2.1% AH after announcing a $60M stock offering - equal to 13.6% of its market cap as of today's close. The company only says it plans to use the proceeds for "general corporate purposes." (prospectus)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
